Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |